a year ago
IRON
AnalystsBenjamin BurnettBenjamin Burnett's Stock Forecasts
AnalystsBenjamin Burnett
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4576 out of 4870 analysts
Average Return
-9.96%
Win Rate
35%21 out of 60
Risk vs Reward
Poor
Good
Benjamin Burnett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +271.38% | $2.76 | $10.25 | 2023-10-18 - 2024-02-21 | Strong Buy |
Cti Biopharma CorpCTIC | +134.68% | $2.22 | $5.21 | 2021-05-05 - 2022-05-05 | Strong Buy |
Arcellx IncACLX | +134.31% | $30.11 | $70.55 | 2023-03-13 - 2024-03-13 | Strong Buy |
Iovance Biotherapeutics IncIOVA | +96.20% | $5.27 | $10.34 | 2023-09-14 - 2024-09-13 | Strong Buy |
Ideaya Biosciences IncIDYA | +92.60% | $20.26 | $39.02 | 2023-04-23 - 2024-04-23 | Strong Buy |
Benjamin Burnett Analyst Color
Get additional color on Benjamin Burnett's coverage of popular stocks
Benjamin Burnett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 5 | Strong Buy | $64.00 | +57.48% | Maintains | a month ago |
Fate Therapeutics IncFATE | 3 | Hold | $3.00 | +141.94% | Maintains | 2 months ago |
Crispr Therapeutics AgCRSP | 7 | Hold | $49.00 | +29.87% | Maintains | 3 months ago |
Disc Medicine IncIRON | 7 | Strong Buy | $94.00 | +89.21% | Maintains | 3 months ago |
Repare Therapeutics IncRPTX | 5 | Strong Buy | $4.00 | +183.69% | Maintains | 5 months ago |
Arcellx IncACLX | 5 | Strong Buy | $122.00 | +86.17% | Maintains | 6 months ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $69.00 | +247.96% | Maintains | 8 months ago |
Ideaya Biosciences IncIDYA | 7 | Strong Buy | $68.00 | +232.19% | Maintains | 8 months ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $86.00 | +1,498.51% | Initiates Coverage On | 10 months ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $32.00 | +2,460.00% | Maintains | a year ago |
Precigen IncPGEN | 3 | Strong Buy | $10.00 | +545.16% | Maintains | a year ago |
Allogene Therapeutics IncALLO | 4 | Hold | $4.60 | +172.19% | Maintains | a year ago |
Atara Biotherapeutics IncATRA | 4 | Hold | $57.50 | N/A | Maintains | a year ago |
Kinnate Biopharma IncKNTE | 5 | Hold | $2.59 | N/A | Maintains | a year ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.25 | N/A | Downgrades | a year ago |
Mirati Therapeutics IncMRTX | 6 | Hold | $59.00 | N/A | Downgrades | a year ago |
Iovance Biotherapeutics IncIOVA | 9 | Strong Buy | $25.00 | N/A | Reiterates | 2 years ago |
Effector Therapeutics IncEFTR | 4 | Strong Buy | $175.00 | N/A | Upgrades | 2 years ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | N/A | Downgrades | 2 years ago |
Neurogene IncNGNE | 2 | Hold | $4.50 | N/A | Downgrades | 2 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | $0.16 | N/A | Downgrades | 3 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $780.00 | N/A | Maintains | 4 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $24.00 | N/A | Upgrades | 4 years ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 4 years ago |
Bluebird Bio IncBLUE | 3 | Strong Buy | $1,400.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.